People

Bart Friedman

Lead independent director of Ovid Therapeutics and chair of its Nominating and Corporate Governance Committee. A corporate governance lawyer with a long career at Cahill Gordon & Reindel and earlier service at the SEC. Holds a JD from Harvard Law School.